1,035
Views
35
CrossRef citations to date
0
Altmetric
Review Article

The role of clofarabine in acute myeloid leukemia

, , &
Pages 688-698 | Received 16 Jul 2012, Accepted 28 Aug 2012, Published online: 28 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Xuelin Huang, Lianchun Xiao, Guillermo Garcia-Manero, William Plunkett, Varsha Gandhi, Koji Sasaki, Naveen Pemmaraju, Naval G. Daver, Gautam Borthakur, Nitin Jain, Marina Konopleva, Zeev Estrov, Tapan M. Kadia, William G. Wierda, Courtney D. DiNardo, Mark Brandt, Susan M. O’Brien, Jorge E. Cortes & Elias Jabbour. (2018) A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia. Leukemia & Lymphoma 59:4, pages 813-820.
Read now
Jimin Shao, Xiyong Liu, Lijun Zhu & Yun Yen. (2013) Targeting ribonucleotide reductase for cancer therapy. Expert Opinion on Therapeutic Targets 17:12, pages 1423-1437.
Read now
Annalisa Lonetti, Sergio Amadori & James A. McCubrey. (2013) Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients. Cell Cycle 12:12, pages 1815-1816.
Read now

Articles from other publishers (32)

Brittany A. Comunale, Robin J. Larson, Erin Jackson-Ward, Aditi Singh, Frances L. Koback & Lilly D. Engineer. (2023) The Functional Implications of Broad Spectrum Bioactive Compounds Targeting RNA-Dependent RNA Polymerase (RdRp) in the Context of the COVID-19 Pandemic. Viruses 15:12, pages 2316.
Crossref
Jean El Cheikh, Ghassan Bidaoui, Ali Atoui, Khodr Terro, Layal Sharrouf, Ammar Zahreddine, Nour Moukalled, Imane Abou Dalle, Ali Bazarbachi, Mohamad Mohty & Remy Dulery. (2023) Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study. Bone Marrow Transplantation 58:6, pages 667-672.
Crossref
Marcus Geer & John Magenau. (2023) Salvaging (with) CloBu4. Transplantation and Cellular Therapy 29:2, pages 69-70.
Crossref
Jingwen Dong, Tingting Zhong, Zhijian Xu, Haiyi Chen, Xianjun Wang, Lili Yang, Zhiyuan Lou, Yuanling Xu, Tingjun Hou, Rongzhen Xu, Weiliang Zhu & Jimin Shao. (2022) Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model. Cancers 14:19, pages 4710.
Crossref
Ping-Ting Mao, Wei-Bao He, Xi Mai, Li-Hua Feng, Na Li, Yi-Jing Liao, Cai-Sheng Zhu, Jian Li, Ting Chen, Shu-Hao Liu, Qi-Ming Zhang & Ling He. (2022) Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors. Bioorganic & Medicinal Chemistry 56, pages 116599.
Crossref
Nurdan Kelesoglu, Betul Karademir-Yilmaz & Kazim Yalcin Arga. 2022.
Shuai Wang, Xiao-Han Yuan, Sai-Qi Wang, Wen Zhao, Xiao-Bing Chen & Bin Yu. (2021) FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. European Journal of Medicinal Chemistry 214, pages 113218.
Crossref
Angela Rodríguez González, Ana Sahores, Antonela Díaz‐Nebreda, Agustín Yaneff, Nicolás Di Siervi, Natalia Gómez, Federico Monczor, Natalia Fernández, Carlos Davio & Carina Shayo. (2020) MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux. The FEBS Journal 288:1, pages 229-243.
Crossref
Alessandra Messikommer, Katja Seipel, Stephen Byrne, Peter J. M. Valk, Thomas Pabst & Nathan W. Luedtke. (2020) RNA Targeting in Acute Myeloid Leukemia. ACS Pharmacology & Translational Science 3:6, pages 1225-1232.
Crossref
Lindsey R. Drake, Ansel T. Hillmer & Zhengxin Cai. (2020) Approaches to PET Imaging of Glioblastoma. Molecules 25:3, pages 568.
Crossref
Agnieszka Kaufman‑Szymczyk, Katarzyna Majda, Agata Szuławska‑Mroczek, Krystyna Fabianowska‑Majewska & Katarzyna Lubecka. (2019) Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis. Molecular Medicine Reports.
Crossref
Louise Bouard, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Alix Duquenne, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, Thomas Gastinne, Yannick Le Bris, Anne Lok, Antoine Bonnet, Steven Le Gouill, Philippe Moreau, Marie C Bene & Patrice Chevallier. (2019) Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies. Biology of Blood and Marrow Transplantation 25:7, pages 1465-1471.
Crossref
Zhaoxing Xu, Yongchao Yang, Xi Mai, Bin Liu, Yuanzhen Xiong, Lihuang Feng, Yijing Liao, Yu Zhang, Huanlu Wang, Leiting Ouyang & Shuhao Liu. (2018) Syntheses and Biological Evaluation of Novel Hydroxamic Acid Derivatives Containing Purine Moiety as Histone Deacetylase Inhibitors. Chemical and Pharmaceutical Bulletin 66:4, pages 439-451.
Crossref
Brenton G. Mar & Barbara A. Degar. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 359 374 .
Vibeke Andresen & Bjørn T. Gjertsen. (2017) Drug Repurposing for the Treatment of Acute Myeloid Leukemia. Frontiers in Medicine 4.
Crossref
Elias Jabbour, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Lianchun Xiao, Guillermo Garcia-Manero, William Plunkett, Varsha Gandhi, Koji Sasaki, Naveen Pemmaraju, Naval G. Daver, Gautam Borthakur, Nitin Jain, Marina Konopleva, Zeev Estrov, Tapan M. Kadia, William G. Wierda, Courtney D. DiNardo, Mark Brandt, Susan M. O'Brien, Jorge E. Cortes & Hagop Kantarjian. (2017) A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia. Cancer 123:22, pages 4430-4439.
Crossref
Christina D. Drenberg, Alice A. Gibson, Stanley B. Pounds, Lei Shi, Dena P. Rhinehart, Lie Li, Shuiying Hu, Guoqing Du, Anne T. Nies, Matthias Schwab, Navjotsingh Pabla, William Blum, Tanja A. Gruber, Sharyn D. Baker & Alex Sparreboom. (2017) OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues. Cancer Research 77:8, pages 2102-2111.
Crossref
Robert B. Diasio. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine 1 12 .
María J. Lapponi, Cintia W. Rivero, María A. Zinni, Claudia N. Britos & Jorge A. Trelles. (2016) New developments in nucleoside analogues biosynthesis: A review. Journal of Molecular Catalysis B: Enzymatic 133, pages 218-233.
Crossref
Patrice Chevallier, Myriam Labopin, Regis Peffault de La Tour, Bruno Lioure, Claude‐Eric Bulabois, Anne Huynh, Didier Blaise, Pascal Turlure, Etienne Daguindau, Natacha Maillard, Ibrahim Yakoub‐Agha, Gaelle Guillerm, Jeremy Delage, Nathalie Contentin, Jacques‐Olivier Bay, Florence Beckerich, Jean‐Henri Bourhis, Marie Detrait, Stéphane Vigouroux, Sylvie François, Faezeh Legrand, Thierry Guillaume & Mohamad Mohty. (2016) Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS. Cancer Medicine 5:11, pages 3068-3076.
Crossref
CD Drenberg, S Hu, L Li, DR Buelow, SJ Orwick, AA Gibson, JD Schuetz, A Sparreboom & SD Baker. (2016) ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression. Clinical and Translational Science 9:1, pages 51-59.
Crossref
Brigitte Nelken, Helene Cave, Guy Leverger, Claire Galambrun, Genevieve Plat, Claudine Schmitt, Caroline Thomas, C?cile V?rit?, Benoit Brethon, Virginie Gandemer, Yves Bertrand, Andr? Baruchel & Pierre Rohrlich. (2016) A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee). Pediatric Blood & Cancer 63:2, pages 270-275.
Crossref
Jung-Suk Choi & Anthony J. Berdis. (2016) Visualizing nucleic acid metabolism using non-natural nucleosides and nucleotide analogs. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1864:1, pages 165-176.
Crossref
Daniel A. Roberts & David P. Steensma. (2015) Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents. Current Hematologic Malignancy Reports 10:3, pages 318-328.
Crossref
Marie-Luise Berres, Miriam Merad & Carl E. Allen. (2015) Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?. British Journal of Haematology 169:1, pages 3-13.
Crossref
Natasha Kekre & John Koreth. (2015) Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes. Current Opinion in Hematology 22:2, pages 116-122.
Crossref
Daniel A. Roberts, Martha Wadleigh, Anne M. McDonnell, Daniel J. DeAngelo, Richard M. Stone & David P. Steensma. (2015) Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. Leukemia Research 39:2, pages 204-210.
Crossref
Marcio Nucci & Elias Anaissie. (2014) How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. Blood 124:26, pages 3858-3869.
Crossref
Takahiro Yamauchi, Kanako Uzui, Rie Nishi, Hiroko Shigemi & Takanori Ueda. (2014) Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line. BMC Cancer 14:1.
Crossref
Kenar D Jhaveri, Shailaja Chidella, Steven L Allen & Steven Fishbane. (2013) Clofarabine-induced kidney toxicity. Journal of Oncology Pharmacy Practice 20:4, pages 305-308.
Crossref
Kelly Faulk, Lia Gore & Todd Cooper. (2014) Overview of Therapy and Strategies for Optimizing Outcomes in De Novo Pediatric Acute Myeloid Leukemia. Pediatric Drugs 16:3, pages 213-227.
Crossref
Meagan A. Jacoby, Michael G. Martin, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio, Amanda Cashen, Keith Stockerl-Goldstein, Ravi Vij, Jingqin Luo, Teresa Reineck, Noel Bernabe & Camille N. Abboud. (2014) Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia. American Journal of Hematology 89:5, pages 487-492.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.